Logo image
IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease
Journal article   Peer reviewed

IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease

P. Price and I. James
AIDS, Vol.23(9), pp.1173-1176
2009
url
Link to Published Version *Subscription may be requiredView

Abstract

Among Australians treated for advanced HIV disease, a suboptimal virological response was associated with allele 2 at interleukin 1 alpha (IL1A)-889 and IL1A+4845. This is confirmed and investigated using patients from AIDS Clinical Trials Group study 384 (n = 532). Among non-African-American patients with CD4 T-cell count of ≤100 cells/μl at baseline, IL1A+4845TT was associated with poor virological outcome (P = 0.03). Differences were smaller with higher baseline CD4 T-cell counts. IL1A-889 and IL1A+4845 were not in linkage disequilibrium in African-American patients, and IL1A+4845T did not affect outcome.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.49 Dentistry & Oral Medicine
1.49.394 Periodontal Microbiome
Web Of Science research areas
Immunology
Infectious Diseases
Virology
ESI research areas
Immunology
Logo image